Product Details:
| Strength | 125 mg |
| Brand | Palbonamo |
| Capsules per Pack | 21 Capsules |
| Usage | Cancer Care |
| Form | Capsule |
| Pack Type | Bottle |
Palbonamo 125 mg (active ingredient palbociclib) is a targeted anti-cancer drug used for hormone receptor-positive, HER2-negative advanced or metastatic breast cancer, working as a CDK 4/6 inhibitor to stop cancer cell growth, usually taken with other medications and food. It helps slow cancer spread but causes side effects like fatigue, hair loss, nausea, infections, and low blood counts, requiring careful monitoring by a doctor.